190 related articles for article (PubMed ID: 31634797)
1. Unlocking the concealed targets using system biology mapping for Alzheimer's disease.
Joshi P; Kawade V; Dhulap S; Goel M
Pharmacol Rep; 2019 Dec; 71(6):1104-1107. PubMed ID: 31634797
[TBL] [Abstract][Full Text] [Related]
2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
3. Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Alzheimers Dis; 2019; 72(s1):S145-S176. PubMed ID: 31594236
[TBL] [Abstract][Full Text] [Related]
4. "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
Rao CV; Asch AS; Carr DJJ; Yamada HY
Aging Cell; 2020 Mar; 19(3):e13109. PubMed ID: 31981470
[TBL] [Abstract][Full Text] [Related]
5. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
8. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
Chatterjee P; Roy D; Rathi N
J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
[TBL] [Abstract][Full Text] [Related]
10. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
11. Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer's Disease.
Singh SK; Kumar A; Singh RB; Ghosh P; Bajad NG
Curr Top Med Chem; 2022; 22(26):2153-2175. PubMed ID: 36305125
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
Mullane K; Williams M
Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
[TBL] [Abstract][Full Text] [Related]
13. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors.
Kuo YC; Rajesh R
Expert Rev Neurother; 2019 Jul; 19(7):623-652. PubMed ID: 31109210
[No Abstract] [Full Text] [Related]
15. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
16. Progress in the development of new drugs in Alzheimer's disease.
Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
[TBL] [Abstract][Full Text] [Related]
17. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
19. Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.
Li H; Wang X; Yu H; Zhu J; Jin H; Wang A; Yang Z
Curr Neuropharmacol; 2018; 16(6):758-768. PubMed ID: 29086699
[TBL] [Abstract][Full Text] [Related]
20. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
Kalra J; Khan A
Eur J Pharmacol; 2015 Oct; 764():571-581. PubMed ID: 26209363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]